Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from Nanologica AB ( (SE:NICA) ) is now available.
Nanologica AB has called an Extraordinary General Meeting for March 4, 2026, in Stockholm, where shareholders will vote on a series of capital structure and governance measures, including the adoption of new Articles of Association and multiple share issues. The board proposes a substantial increase in the permitted share capital range and number of shares to enable a planned rights issue and related directed and set-off share issues, as well as authorization for additional share issues to underwriters, a package that would significantly expand the company’s equity base and dilute existing holdings while potentially strengthening its financial position and strategic flexibility for future growth.
The most recent analyst rating on (SE:NICA) stock is a Sell with a SEK0.51 price target. To see the full list of analyst forecasts on Nanologica AB stock, see the SE:NICA Stock Forecast page.
More about Nanologica AB
Nanologica AB is a Swedish public company listed in Södertälje, operating in the life science/technology sector. The company has 88,369,820 outstanding shares and no treasury shares, and is governed under Swedish corporate law with its shares registered through Euroclear Sweden AB.
Average Trading Volume: 168,106
Technical Sentiment Signal: Strong Sell
Current Market Cap: SEK50.19M
Learn more about NICA stock on TipRanks’ Stock Analysis page.